A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382

α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

(1998) · Europe PMC (PubMed Central) · Cited by 1,594

Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,520

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J. D. M., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,469

The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316

Identification of two distinct synucleins from human brain

Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080

Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Cairns, N. J., Lantos, P. L., & Goedert, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00504-7 · Cited by 1,052

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch

George, J. M., Jin, H., Woods, W. S., & Clayton, D. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90040-3 · Cited by 844

Effect of β-cyclodextrin-EGCG complexion against aggregated a-synuclein through density functional theory and discrete molecular dynamics

Srinivasan, E., & Rajasekaran, R. (2019) · Chemical Physics Letters · doi:10.1016/j.cplett.2018.12.042 · Cited by 14

Keeping α-Synuclein at Bay: A More Active Role of Molecular Chaperones in Preventing Mitochondrial Interactions and Transition to Pathological States?

Aspholm, E. E., Matečko‐Burmann, I., & Burmann, B. M. (2020) · Life · doi:10.3390/life10110289 · Cited by 13

Alpha-synuclein transgenic mice: Relevance to multiple system atrophy

Fillon, G., & Kahle, P. J. (2005) · Movement Disorders · doi:10.1002/mds.20542 · Cited by 13

Role of Saturation and Length of Fatty Acids of Phosphatidylserine in the Aggregation of Transthyretin

Ali, A., Zhaliazka, K., Dou, T., Holman, A. P., & Kurouski, D. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00357 · Cited by 12

⍺-Synuclein levels in Parkinson's disease – Cell types and forms that contribute to pathogenesis

Sagredo, G. T., Tanglay, O., Shahdadpuri, S., Fu, Y., & Halliday, G. M. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114887 · Cited by 13

Glycation Produces Topologically Different α-Synuclein Oligomeric Strains and Modulates Microglia Response via the NLRP3-Inflammasome Pathway

Kumari, M., Bisht, K. S., Ahuja, K., Motiani, R. K., & Maiti, T. K. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00057 · Cited by 15

PLK2 disrupts autophagic flux to promote SNCA/α-synuclein pathology

Zhang, C., Huang, Z.-P., Huang, X., Ma, Y., Cao, Y., Zhang, Z., Wang, R., Ren, H., Zheng, L. T., Liu, C.-F., et al. (2025) · Autophagy · doi:10.1080/15548627.2024.2448914 · Cited by 12

Buffering capacity is determinant for restoring early α-synuclein aggregation

Saraiva, M. A., & Florêncio, M. H. (2022) · Biophysical Chemistry · doi:10.1016/j.bpc.2022.106760 · Cited by 12

Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformations

Buratti, F. A., Böffinger, N. M., Garro, H. A., Flores, J. S., Hita, F. J., Gonçalves, P. D. C., Copello, F. D. R., Lizárraga, L., Rossetti, G., Carloni, P., et al. (2022) · Protein Science · doi:10.1002/pro.4360 · Cited by 12

The Therapeutic Potential of LRRK2 and α-Synuclein in Parkinson's Disease

Sen, S., & West, A. B. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2430 · Cited by 12

Dammarane triterpenes targeting α-synuclein: biological activity and evaluation of binding sites by molecular docking

Cornejo, A., Caballero, J., Simirgiotis, M. J., Torres, V., Sanchez, L. E. M., Díaz, N., Guimaraes, M., Hernández, M., Areche, C., Alfaro, S., et al. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1851216 · Cited by 12

Partial magic angle spinning NMR 1H, 13C, 15N resonance assignments of the flexible regions of a monomeric alpha-synuclein: conformation of C-terminus in the lipid-bound and amyloid fibril states

Medeiros, J., Bamm, V. V., Jany, C., Coackley, C. L., Ward, M. E., Harauz, G., Ryan, S. D., & Ladizhansky, V. (2021) · Biomolecular NMR Assignments · doi:10.1007/s12104-021-10020-z · Cited by 12

Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicity

Smith, L. M., Klaver, A. C., Coffey, M. P., Dang, L., & Loeffler, D. A. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.09.007 · Cited by 12

Pathological looping in the synucleinopathies: investigating the link between Parkinson’s disease and Gaucher disease

Kinghorn, K. J. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.008615 · Cited by 12

Studies of the aggregation of an amyloidogenic α-synuclein peptide fragment

Madine, J., Doig, A. J., Kitmitto, A., & Middleton, D. A. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331113 · Cited by 12

Neuropathology of Parkinson's Disease

Petrucelli, L., & Dickson, D. W. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00003-8 · Cited by 12

The aggregation and membrane-binding properties of an α-synuclein peptide fragment

Madine, J., Doig, A. J., & Middleton, D. A. (2004) · Biochemical Society Transactions · doi:10.1042/bst0321127 · Cited by 12

Following the leader: fibrillization of ?-synuclein and tau

Frasier, M. A. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.02.008 · Cited by 12

Caenorhabditis Elegans as a Model for Human Synucleopathies

Vartiainen, S. (2007) · Cited by 12

Quiescent Elongation of α-Synuclein Pre-form Fibrils Under Different Solution Conditions

Mao, H., Ye, Y., Sun, X., Qian, C., Wang, B., Xie, L., & Zhang, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.902077 · Cited by 12

Naphthoquinone–dopamine hybrids disrupt α-synuclein fibrils by their intramolecular synergistic interactions with fibrils and display a better effect on fibril disruption

Zhou, Y., Yao, Y., Yang, Z., Tang, Y., & Wei, G. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d3cp00340j · Cited by 11

β-Synuclein Intermediates α-Synuclein Neurotoxicity in Parkinson’s Disease

Xian, M., Li, J., Liu, T., Hou, K., Sun, L., & Wei, J. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00263 · Cited by 11

Analysis and comparison of post-translational modifications of α-synuclein filaments in multiple system atrophy and dementia with Lewy bodies

Kametani, F., Tahira, M., Takao, M., Matsubara, T., Hasegawa, K., Yoshida, M., Saito, Y., Murayama, S., & Hasegawa, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-74130-z · Cited by 12

Mitochondrial Dysfunction in Parkinson’s Disease: A Contribution to Cognitive Impairment?

Scorziello, A., Sirabella, R., Sisalli, M. J., Tufano, M., Giaccio, L., D’Apolito, E., Castellano, L., & Annunziato, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111490 · Cited by 11

α-synuclein as a promising biomarker for developing diagnostic tools against neurodegenerative synucleionopathy disorders

Bagree, G., Silva, O. D., Liyanage, P. D., Ramarathinam, S. H., Sharma, S., Bansal, V., & Ramanathan, R. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.116922 · Cited by 11

Over-expression of α-synuclein 98 triggers intracellular oxidative stress and enhances susceptibility to rotenone

Ma, K., Yuan, Y., Song, L.-K., Han, N., & Chen, N. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.026 · Cited by 11

Oligomerization of ribonuclease A under reducing conditions

Gotte, G., & Libonati, M. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.12.013 · Cited by 11

The effect of tyrosine residues on α-synuclein fibrillation

Pirc, K., Škarabot, M., Pogačnik, L., Žerovnik, E., & Ulrih, N. P. (2015) · Acta chimica slovenica · doi:10.17344/acsi.2014.882 · Cited by 11

A Capped Peptide of the Aggregation Prone NAC 71–82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations

Näsström, T., Ådén, J., Shibata, F., Andersson, P. O., & Karlsson, B. C. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051629 · Cited by 11

Protein Folding and Aggregation in in vitro Models of Parkinson's Disease

Eliezer, D. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00042-7 · Cited by 11

Using leucine zipper to facilitate α‐synuclein assembly

Jiang, P., Ko, L., Jansen, K. R., Golde, T. E., & Yen, S.-H. C. (2008) · The FASEB Journal · doi:10.1096/fj.08-108365 · Cited by 11

Immunization Effects of a Novel α-Synuclein-Based Peptide Epitope Vaccine in Parkinson’s Disease-Associated Pathology

Park, J. S., Ahmad, R., Choe, K., Kang, M. H., Park, T. J., & Kim, M. O. (2023) · Vaccines · doi:10.3390/vaccines11121820 · Cited by 10

Liquid–liquid phase separation and conformational strains of α-Synuclein: implications for Parkinson’s disease pathogenesis

Ruiz, E., Wilkaniec, A., & Adamczyk, A. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1494218 · Cited by 11

Parkinson’s paradox: alpha-synuclein’s selective strike on SNc dopamine neurons over VTA

Phan, L. T., Miller, D., Gopinath, A., Lin, M., Gunther, D., Kiel, K., Quintin, S., Borg, D., Segherlou, Z. H., Newman, A., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01055-3 · Cited by 12

Oleuropein Aglycone, an Olive Polyphenol, Influences Alpha-Synuclein Aggregation and Exerts Neuroprotective Effects in Different Parkinson’s Disease Models

Basellini, M. J., Granadino‐Roldán, J. M., Torres-Ortega, P. V., Simmini, G., Rubio, J., Marín, S., Cappelletti, G., Cascante, M., & Cañuelo, A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05208-6 · Cited by 11

Ultrastiff Amyloid-Fibril Network of α-Synuclein Formed by Surface Seeding Reaction Confirmed by Multichannel Electrodeless Quartz-Crystal-Microbalance Biosensor

Zhou, L., Hajiri, T., Nakajima, K., Aguirre, C., Ikenaka, K., Mochizuki, H., Yamaguchi, K., Goto, Y., & Ogi, H. (2023) · ACS Sensors · doi:10.1021/acssensors.3c00331 · Cited by 10

Length and saturation of fatty acids in phosphatidylserine determine the rate of lysozyme aggregation simultaneously altering the structure and toxicity of amyloid oligomers and fibrils

Frese, A., Goode, C., Zhaliazka, K., Holman, A. P., Dou, T., & Kurouski, D. (2023) · Protein Science · doi:10.1002/pro.4717 · Cited by 10

Pyrazolamide derivatives inhibit α-Synuclein aggregation, disaggregate preformed fibers, and reduce inclusion formation in neuron cells

Xing, L.-Z., Zhang, W., Zhao, Y.-D., Xu, J. P., & Zhang, Y. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116198 · Cited by 10

Macrophages and Natural Killers Degrade α-Synuclein Aggregates

Matveyenka, M., Zhaliazka, K., & Kurouski, D. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00160 · Cited by 10

Elucidating the mechanisms of α-Synuclein-lipid interactions using site-directed mutagenesis

Ali, A., Holman, A. P., Rodriguez, A., Osborne, L., & Kurouski, D. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106553 · Cited by 10

Minimal Nucleation State of α-Synuclein Is Stabilized by Dynamic Threonine–Water Networks

Romo, T. D., Lewis, A. K., Braun, A. R., Grossfield, A. M., & Sachs, J. N. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00171 · Cited by 10

Importance of Solvent in Guiding the Conformational Properties of an Intrinsically Disordered Peptide

Mondal, S., Mondal, S., & Bandyopadhyay, S. (2021) · Langmuir · doi:10.1021/acs.langmuir.1c02401 · Cited by 10

Phase separation and other forms of α-Synuclein self-assemblies

Poudyal, M., Sakunthala, A., Mukherjee, S., Gadhe, L. G., & Maji, S. K. (2022) · Essays in Biochemistry · doi:10.1042/ebc20220055 · Cited by 10

Creation of Aggregation‐Defective α‐Synuclein Variants by Engineering the Sequence Connecting β‐Strand‐Forming Domains

Hernandez, M. X., Golbert, S., Zhang, L. G., & Kim, J. R. (2011) · ChemBioChem · doi:10.1002/cbic.201100430 · Cited by 10

Fluorescence Lifetime Distribution Brings Out Mechanisms Involving Biomolecules While Quantifying Population Heterogeneity

Krishnamoorthy, G. (2018) · Reviews in fluorescence · doi:10.1007/978-3-030-01569-5_4 · Cited by 10

Biochemistry & Pharmacology: Open Access

(2020) · doi:10.35248/2167-0501 · Cited by 10

Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicity

Noelker, C., Seitz, F., Sturn, A., Neff, F., Andrei‐Selmer, L., Rau, L., Geyer, A., Ross, J. A., Bacher, M., & Dodel, R. C. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103390 · Cited by 9

Structure of a Parkinson’s Disease-Involved α-Synuclein Peptide Is Modulated by Membrane Composition and Physical State

Martial, B., Raîche-Marcoux, G., Lefèvre, T., Audet, P., Voyer, N., & Auger, M. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c00945 · Cited by 9

Triiodide ion-induced inhibition of amyloid aggregate formation: A case study of α-synuclein

Takekiyo, T., Yamada, N., Amo, T., Asano, A., & Yoshimura, Y. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.119446 · Cited by 9

Unravelling the destabilization potential of ellagic acid on α-synuclein fibrils using molecular dynamics simulations

Mankoo, O. K., Kaur, A., Goyal, D., & Goyal, B. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp06006j · Cited by 9

Conformational dynamics of A30G α-synuclein that causes familial Parkinson disease

Das, D., & Mattaparthi, V. S. K. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2193997 · Cited by 9

Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid

Aubrey, L. D., Ninkina, N. N., Ulamec, S. M., Abramycheva, N. Y., Vasili, E., Devine, O. M., Wilkinson, M., Mackinnon, E., Limorenko, G., Walko, M., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2309700120 · Cited by 10

Molecular Insights into α-Synuclein Fibrillation: A Raman Spectroscopy and Machine Learning Approach

Coles, N. P., Elsheikh, S., Quesnel, A., Butler, L., Jennings, C., Tarzi, C., Achadu, O. J., Islam, M., Kalesh, K., Occhipinti, A., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00726 · Cited by 9

Collagen mimetic peptide discs promote assembly of a broad range of natural protein fibers through hydrophobic interactions

McGuinness, K. N., & Nanda, V. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob01073g · Cited by 9

Protein aggregation-inhibition: a therapeutic route from Parkinson’s disease to sickle cell anemia

Martins, G. F., & Galamba, N. (2023) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2023.2201406 · Cited by 9

Alpha‐Synuclein Dopaminylation Presented in Plasma of Both Healthy Subjects and Parkinson's Disease Patients

Zhao, H., Huang, S., Palanisamy, S., Wang, C., Rainer, G., & Zhang, X. (2020) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201900117 · Cited by 9

Site-specific structural dynamics of α -Synuclein revealed by time-resolved fluorescence spectroscopy: a review

Sahay, S., Krishnamoorthy, G., & Maji, S. K. (2016) · Methods and Applications in Fluorescence · doi:10.1088/2050-6120/4/4/042002 · Cited by 9

Amyloidogenicity at a Distance: How Distal Protein Regions Modulate Aggregation in Disease

LUCATO, C. M. A., Lupton, C. J., Halls, M. L., & Ellisdon, A. M. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.03.021 · Cited by 9

An Innate Host Defense Protein β2-Microglobulin Keeps a Check on α-Synuclein amyloid Assembly: Implications in Parkinson's Disease

Rani, K., Pal, A., Gurnani, B., Agarwala, P., Sasmal, D. K., & Jain, N. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168285 · Cited by 8

Ultrastructures of α-Synuclein Filaments in Synucleinopathy Brains and Experimental Models

Tarutani, A., & Hasegawa, M. (2023) · Journal of Movement Disorders · doi:10.14802/jmd.23213 · Cited by 9

Therapeutic potential of Coumarin-polyphenolic acid hybrids in PD: Inhibition of α-Syn aggregation and disaggregation of preformed fibrils, leading to reduced neuronal inclusion formation

Wang, Z., Zhang, W., Xing, L.-Z., Zhao, Y., Xu, J. P., & Zhang, Y. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129618 · Cited by 8

Alpha-Synuclein and GM1 Ganglioside Co-Localize in Neuronal Cytosol Leading to Inverse Interaction—Relevance to Parkinson’s Disease

Kumar, R., Chowdhury, S., & Ledeen, R. W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063323 · Cited by 8

Unveiling Parkinson’s disease through biomarker research: current insights and future prospects

Çelik, N. D., Özben, S., & Özben, T. (2024) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2024.2331471 · Cited by 8

Mono‐Substituted Hydrocarbon Diastereomer Combinations Reveal Stapled Peptides with High Structural Fidelity

McWhinnie, F. S., Sepp, K., Wilson, C., Kunath, T., Hupp, T. R., BAKER, T. S., Houston, D. R., & Hulme, A. N. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201705983 · Cited by 8

Adsorption and decontamination of α-synuclein from medically and environmentally-relevant surfaces

Phan, H. T. M., Bartz, J. C., Ayers, J. I., Giasson, B. I., Schubert, M. M., Rodenhausen, K. B., Kananizadeh, N., Li, Y., & Bartelt‐Hunt, S. L. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.03.011 · Cited by 8

Direct Identification of Amyloid Peptide Fragments in Human α-Synuclein Based on Consecutive Hydrophobic Amino Acids

Chen, Y., Peng, F., Su, T., Yang, H., & Qiu, F. (2020) · ACS Omega · doi:10.1021/acsomega.0c00979 · Cited by 8

Unravelling the potency of triazole analogues for inhibiting α-synuclein fibrillogenesis and in vitro disaggregation

Maqbool, M., Gadhavi, J. D., Singh, A., Hivare, P., Gupta, S. K., & Hoda, N. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob02226h · Cited by 8

Insight into conformational modification of alpha‐synuclein in the presence of neuronal whole cells and of their isolated membranes

Smaldone, G., Diana, D., Pollegioni, L., Gaetano, S. D., Fattorusso, R., & Pedone, E. M. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.02.012 · Cited by 9

Aggregation properties of a short peptide that mediates amyloid fibril formation in model proteins unrelated to disease

Chaudhary, N., Singh, S. S., & Nagaraj, R. (2011) · Journal of Biosciences · doi:10.1007/s12038-011-9104-3 · Cited by 8

Mapping of Surface-Exposed Epitopes of In Vitro and In Vivo Aggregated Species of Alpha-Synuclein

Almandoz-Gil, L., Lindström, V., Sigvardson, J., Kahle, P. J., Lannfelt, L., Ingelsson, M., & Bergström, J. J. E. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0454-0 · Cited by 8

Pre-structured hydrophobic peptide β-strands: A universal amyloid trap?

Sivanesam, K., & Andersen, N. H. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.01.032 · Cited by 8

Novel Molecular Targets and Mechanisms for Neuroprotective Modulation in Neurodegenerative Disorders

Irannejad, H., Azari, A., Goodarzi, A., Jafarkhani, B., Eghbali, M., Karimi, Z., & Balef, S. S. H. (2022) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524922666220616092132 · Cited by 8

Toward Peptide-Based Inhibitors as Therapies for Parkinson's Disease

Mason, J. M., & Fairlie, D. P. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.139 · Cited by 8

Microscopic Understanding of the Conformational Stability of the Aggregated Nonamyloid β Components of α-Synuclein

Mondal, S., Ghanta, K. P., & Bandyopadhyay, S. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01540 · Cited by 7

The α-Synuclein Monomer May Have Different Misfolding Mechanisms in the Induction of α-Synuclein Fibrils with Different Polymorphs

Zhao, N., Zhang, Q., Yu, F., Yao, X., & Liu, H. (2023) · Biomolecules · doi:10.3390/biom13040682 · Cited by 7

(Dys)functional insights into nucleic acids and RNA-binding proteins modulation of the prion protein and α-synuclein phase separation

Cordeiro, Y., Freire, M. H. O., Wiecikowski, A. F., & do Amaral, M. J. (2023) · Biophysical Reviews · doi:10.1007/s12551-023-01067-4 · Cited by 7

Different charged biopolymers induce α-synuclein to form fibrils with distinct structures

Yao, Y., Zhao, Q., Tao, Y., Liu, K., Cao, T., Chen, Z., Liu, C., Le, W., Zhao, J., Li, D., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107862 · Cited by 7

α-synuclein folds: the cards are on the table

Peelaerts, W., & Baekelandt, V. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3209 · Cited by 8

Chicago sky blue 6B inhibits α-synuclein aggregation and propagation

Min, J.-O., Strohäker, T., Jeong, B., Zweckstetter, M., & Lee, S. (2022) · Molecular Brain · doi:10.1186/s13041-022-00913-y · Cited by 7

A glimpse into the structural properties of α‐synuclein oligomers

Santos, J., Pallarès, I., & Ventura, S. (2023) · BioFactors · doi:10.1002/biof.2021 · Cited by 7

The Hsp70 Chaperone System in Parkinson’s Disease

Labrador‐Garrido, A., Carlos, W., & Roodveldt, C. (2011) · InTech eBooks · doi:10.5772/16671 · Cited by 7

Dynamical properties of α-synuclein in soluble and fibrillar forms by Quasi Elastic Neutron Scattering

Bousset, L., Brewee, C., Melki, R., & Migliardo, F. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.04.010 · Cited by 7

Two Distinct Polymorphic Folding States of Self-Assembly of the Non-amyloid-β Component Differ in the Arrangement of the Residues

Pollock-Gagolashvili, M., & Miller, Y. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00334 · Cited by 7

A peptide‐display protein scaffold to facilitate single molecule force studies of aggregation‐prone peptides

Doherty, C. P. A., Young, L. M., Karamanos, T. K., Smith, H. I., Jackson, M. P., Radford, S. E., & Brockwell, D. J. (2018) · Protein Science · doi:10.1002/pro.3386 · Cited by 7

Predicting the location of the non-local contacts in α-synuclein

Bergasa-Caceres, F., & RABITZ, H. A. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.09.006 · Cited by 7

Nitroalkylation of α-Synuclein by Nitro-Oleic Acid: Implications for Parkinson’s Disease

Chavarría, C., Trostchansky, A., Durán, R., Rubbo, H., & Souza, J. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11488-6_11 · Cited by 7

Investigating the neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathy

Sargent, D., Bétemps, D., Drouyer, M., Verchère, J., Gaillard, D., Arsac, J.-N., Lakhdar, L., Salvetti, A., & Baron, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-35825-2 · Cited by 7

Alpha Synuclein and Parkinson’s Disease

Parihar, A., Parihar, P., Solanki, I., & Parihar, M. S. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_1 · Cited by 8

Amyloids as Sensors and Protectors (ASAP) Hypothesis

Chapa, R. P., Emery, M. A., Fawver, J. N., & Murray, I. V. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112015 · Cited by 7

Electrostatic screening and backbone preferences of amino acid residues in urea‐denatured ubiquitin

Avbelj, F., & Grdadolnik, S. G. (2007) · Protein Science · doi:10.1110/ps.062484407 · Cited by 7

Oxidative Neural Injury

Veasey, S. C. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-342-8 · Cited by 7

Mitochondrial Injury: A Hot Spot for Parkinsonism and Parkinson's Disease?

Giasson, B. I. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.48.pe42 · Cited by 7

Spatiotemporal solidification of α-synuclein inside the liquid dropletsPreprint

Ray, S., Chatterjee, D., Mukherjee, S., Patel, K., Mahato, J., Kadam, S., Krishnan, R., Sawner, A. S., Poudyal, M., Krishnamoorthy, G., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.20.465113 · Cited by 7

Cholesterol dysregulation in APOE4 astrocytes promotes α-synuclein pathology in miBrains

Mesentier-Louro, L. A., Goldman, C., Gaese, S., Buonfiglioli, A., Kyriakis, D., Harlock, A., Ndayisaba, A., Sartori, E. R., Uchitelev, A., Fullard, J. F., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.08.001 · Cited by 6

Emergence of the Synucleins

Marı́n, I. (2023) · Biology · doi:10.3390/biology12081053 · Cited by 6

Nonintuitive Immunogenicity and Plasticity of Alpha-Synuclein Conformers: A Paradigm for Smart Delivery of Neuro-Immunotherapeutics

Abioye, A. O., Akintade, D. D., Mitchell, J., Olorode, S., & Adejare, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050609 · Cited by 7

Salvianolic acid B prevents the amyloid transformation of A53T mutant of α-synuclein

Akhtar, A., Singh, P., Admane, N., & Grover, A. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2024.107379 · Cited by 6

Disease modifying therapies for Parkinson's disease: Novel targets

Vijiaratnam, N., & Foltynie, T. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108839 · Cited by 6

Demonstration of three dopamine molecules bound to α-Synuclein: Implication of oligomerization at the initial stage

Shimotakahara, S., Shiroyama, Y., Fujimoto, T., Akai, M., Onoue, T., Seki, H., Kado, S., Machinami, T., Shibusawa, Y., Uéda, K., et al. (2012) · Journal of Biophysical Chemistry · doi:10.4236/jbpc.2012.32017 · Cited by 6

Mitochondrial-membrane association of α-synuclein: Pros and cons in consequence of Parkinson's disease pathophysiology

Pariary, R., Bhattacharyya, D., & Bhunia, A. (2019) · Gene Reports · doi:10.1016/j.genrep.2019.100423 · Cited by 6

Characterization of Hydrophobic Residue Requirements for α-Synuclein Fibrillization

Waxman, E. A., Mazzulli, J. R., & Giasson, B. I. (2009) · Biochemistry · doi:10.1021/bi900539p · Cited by 110

A Peptide Motif Consisting of Glycine, Alanine, and Valine Is Required for the Fibrillization and Cytotoxicity of Human α-Synuclein

Du, H., Tang, L., Luo, X., Li, H., Hu, J., Zhou, J., & Hu, H. (2003) · Biochemistry · doi:10.1021/bi034028+ · Cited by 155

Sequence determinants regulating fibrillation of human α-synuclein

Koo, H.-J., Lee, H.-J., & Im, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.140 · Cited by 55

Sequence Determinants for Amyloid Fibrillogenesis of Human α-Synuclein

Zibaee, S., Jakes, R., Fraser, G. M., Serpell, L. C., Crowther, R. A., & Goedert, M. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.09.039 · Cited by 67

A de novo designed α-helical peptide forms amyloid fibrils which are not neurotoxic

Fezoui, Y., Hartley, D. M., Walsh, D. M., Selkoe, D. J., Osterhut, J. J., & Teplow, D. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)82568-3